BRPI0511069A - inibidores de proteìnas regiii como terapêutica para asma - Google Patents

inibidores de proteìnas regiii como terapêutica para asma

Info

Publication number
BRPI0511069A
BRPI0511069A BRPI0511069-6A BRPI0511069A BRPI0511069A BR PI0511069 A BRPI0511069 A BR PI0511069A BR PI0511069 A BRPI0511069 A BR PI0511069A BR PI0511069 A BRPI0511069 A BR PI0511069A
Authority
BR
Brazil
Prior art keywords
asthma
therapy
protein inhibitors
inhibitors
methods
Prior art date
Application number
BRPI0511069-6A
Other languages
English (en)
Inventor
Maximillian Follettie
Debra D Donaldson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0511069A publication Critical patent/BRPI0511069A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/474—Pancreatic thread protein; Reg protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

INIBIDORES DE PROTEìNAS REGIII COMO TERAPêUTICA PARA ASMA. A presente invenção refere-se a métodos de varredura de agentes para tratar asma. Os métodos envolvem varrer agentes que diminuem a produção ou atividade de uma proteína RegIII que se descobriu aqui desempenhar um papel na produção dos sintomas e complicações patológicas envolvidas em asma. Métodos de tratamento de asma, bem como varredura para e tratamento com inibidores de uma proteína RegIII são também proporcionados.
BRPI0511069-6A 2004-06-04 2005-06-03 inibidores de proteìnas regiii como terapêutica para asma BRPI0511069A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57725804P 2004-06-04 2004-06-04
PCT/US2005/019594 WO2005118615A1 (en) 2004-06-04 2005-06-03 Inhibitors of regiii proteins as asthma therapeutics

Publications (1)

Publication Number Publication Date
BRPI0511069A true BRPI0511069A (pt) 2007-11-27

Family

ID=35462880

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511069-6A BRPI0511069A (pt) 2004-06-04 2005-06-03 inibidores de proteìnas regiii como terapêutica para asma

Country Status (9)

Country Link
US (1) US20090214516A1 (pt)
EP (1) EP1751174A4 (pt)
JP (1) JP2008512086A (pt)
CN (1) CN1964987A (pt)
AU (1) AU2005250478A1 (pt)
BR (1) BRPI0511069A (pt)
CA (1) CA2568345A1 (pt)
MX (1) MXPA06014091A (pt)
WO (1) WO2005118615A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1900749A1 (en) * 2006-09-12 2008-03-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
CN115252763A (zh) * 2021-04-30 2022-11-01 华东师范大学 Reg3a-dgtm光敏水凝胶组合物及其诱导表皮再生修复创面的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
US6664227B1 (en) * 1996-03-01 2003-12-16 Genetics Institute, Llc Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
US5935813A (en) * 1997-03-20 1999-08-10 Incyte Pharmaceuticals, Inc. Human pancreatitis-associated protein

Also Published As

Publication number Publication date
US20090214516A1 (en) 2009-08-27
WO2005118615A1 (en) 2005-12-15
MXPA06014091A (es) 2007-01-31
EP1751174A1 (en) 2007-02-14
CA2568345A1 (en) 2005-12-15
JP2008512086A (ja) 2008-04-24
EP1751174A4 (en) 2008-07-23
AU2005250478A1 (en) 2005-12-15
CN1964987A (zh) 2007-05-16

Similar Documents

Publication Publication Date Title
ATE408412T1 (de) Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
MX2010008206A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf.
TW200833843A (en) Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof
DOP2008000018A (es) Anticuerpos anti-ige
BR112012022513A2 (pt) derivados de piperidin-4-il azetidina como inibidores de jak1
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
BR112014004319A2 (pt) compostos e composições como inibidores de c-kit cinase
NO20084747L (no) Tetrahydropteridiner anvendbare som inhibitorer av protein kinaser
MX2009004324A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematologicas.
DE602006012013D1 (de) Proteasom-hemmer und verwendungsverfahren dafür
BRPI0911176B8 (pt) método de tratar uma composição de célula vermelha sanguínea, composição de célula vermelha sanguínea, e método de reduzir a desidratação em uma composição de célula vermelha sanguínea
BR112013010899A8 (pt) Curativo com uma camada de biocelulose com acabamento adsorvente de bactérias
EA201070187A1 (ru) Модифицированные ферменты лецитин-холестерин ацилтрансферазы
WO2005112981A3 (en) Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
BRPI0815474A8 (pt) Método para produzir um alimento ou bebida à base de malte apropriado para consumo por um indivíduo com doença celíaca
WO2009152480A3 (en) Methods to treat solid tumors
UY30927A1 (es) Miembros de union para moleculas ige
EA201101643A1 (ru) ВАРИАНТЫ ПРИМЕНЕНИЯ IL-1β АНТИТЕЛ И ИХ СВЯЗЫВАЮЩИХ ФРАГМЕНТОВ В СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЕ
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
DE602006016735D1 (de) Verfahren zur proliferation von stammzellen
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
BRPI0508177A (pt) composto, processo para a produção do composto, composição farmacêutica, uso do composto método para o tratamento de uma doença e produto de combinação
EA200702094A1 (ru) Производные гетероарилмочевины, пригодные для ингибирования chk1

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.